Sciatica PRO+ Side Effects and Cautions

For a healthy adult taking two capsules a day, the honest expectation is nothing at all. These are ingredients with long records of ordinary use and most of the amounts on this panel are modest.

The exceptions are specific rather than general, and they are worth naming precisely instead of being folded into a vague warning. Four belong to particular ingredients and particular circumstances: alpha lipoic acid and blood glucose, folic acid alongside vitamin B12, ashwagandha with thyroid or liver conditions, and turmeric beside anticoagulant medicines.

A fifth point is about totals rather than about this bottle, and a sixth is not a side effect at all but the set of symptoms that would make any of this beside the point. All six have their own section below.

This is the most important interaction on the panel, and it belongs to the largest amount on it.

Alpha lipoic acid improves glucose uptake and can lower blood sugar. In a person with normal glucose control and no medication, that passes unnoticed. In a person taking insulin, a sulfonylurea or another glucose-lowering drug, it adds a second push in the same direction, and the result can be a reading lower than the prescription was calibrated for.

There is also a rarer mechanism worth knowing about. A published case report describes severe hypoglycaemia in a person without diabetes, caused by insulin autoimmune syndrome triggered by alpha lipoic acid in a genetically susceptible individual. That is uncommon, and it is documented rather than theoretical.

The second effect from the trial programme is more mundane. Nausea was the dose-limiting problem in SYDNEY 2, rising with the amount given, which is part of why 600 mg rather than 1,200 or 1,800 mg became the reference dose. At 400 mg it is less likely, and taking the capsules with a meal is the usual answer when it happens.

This formula carries both folic acid and vitamin B12, which is the combination that makes the point below worth spelling out.

A B12 deficiency does two separate things. It causes a particular kind of anaemia, which shows up on an ordinary blood count, and it damages nerves, which does not. Folic acid can correct the anaemia while leaving the nerve damage to continue quietly, which removes the very sign that would normally prompt a clinician to look for the deficiency in the first place.

At 230 mcg of folic acid the risk here is small, and the amount sits well beneath the 1,000 mcg daily upper limit that expert committees have set. The principle behind it is not small at all. The clinical literature on B12 deficiency is clear that early correction can reverse nerve damage and late correction often cannot, so anything that delays the diagnosis carries a real cost.

Some groups should treat that as a prompt rather than a footnote. People over fifty absorb less B12 from food; vegans and strict vegetarians take in almost none; and long-term metformin users lose absorption over time, which a 2026 scoping review found is frequently not monitored.

Twenty-five milligrams of root powder is a small amount, and two cautions still belong on the record because they are documented and because buyers frequently take ashwagandha from more than one source at once.

The thyroid signal comes from an eight-week randomised trial in subclinical hypothyroidism, in which 600 mg a day of root extract shifted thyroid hormone levels. That was presented as a benefit in that population. In someone whose thyroid replacement has been carefully titrated, a shift is not a benefit.

The liver signal is more serious and comes from a case series from Iceland and the U.S. Drug-Induced Liver Injury Network, in which jaundice appeared between two and twelve weeks after people started ashwagandha products. The NIH LiverTox monograph reviews the same pattern.

NCCIH advises against ashwagandha in thyroid disease and autoimmune conditions, during pregnancy, and in the run-up to surgery, and notes that the products involved in liver cases were generally concentrated extracts rather than raw powder.

Two points about turmeric matter to a minority of readers. Memorial Sloan Kettering notes that it may raise bleeding risk in people taking warfarin or other blood thinners, and NCCIH reports liver damage in some people using high-bioavailability curcumin products.

Both cautions are attached to concentrated preparations rather than to culinary spice. This panel carries 25 mg of root powder, which supplies roughly 0.8 mg of curcumin, and curcumin in that form is poorly absorbed even when taken by the gram. The realistic risk from this row alone is very small.

The reason to mention it anyway is that anticoagulation is unforgiving of surprises. Anyone whose warfarin dose is managed by regular blood tests should be telling whoever manages it about everything they take, and a supplement containing turmeric belongs on that list regardless of how little of it there is.

Vitamin B6 is the one nutrient on this panel with a well-documented harm at the wrong end of the scale, and it is worth understanding correctly rather than worrying about incorrectly.

Too little B6 causes neuropathy. So does far too much: a 1983 case series described sensory neuropathy in people taking very large daily amounts of pyridoxine over long periods, and the finding has been repeated since. The amounts involved were orders of magnitude above a daily requirement.

This label carries 1.7 mg, which is exactly the adult requirement and nowhere near the range where trouble has been described. Taken on its own, this product raises no B6 question at all.

The issue is arithmetic across a shelf. A multivitamin, an energy drink, a B-complex and a nerve formula can each contribute, and no label adds up the others for you. The same logic applies to alpha lipoic acid, since standalone capsules are commonly sold at 600 mg and one taken alongside this formula puts the day at 1,000 mg.

This desk holds no adverse-event reports for the stock it ships. That is a statement about a limited order history rather than a safety finding, and it should not be read as one.

Most of the column on the left resolves by taking the serving with food, which is why that advice appears on the usage page as well. None of these is a reason to push through discomfort: a supplement causing symptoms is a supplement to stop, and the 60-day window covers opened bottles for exactly this situation.

• Anyone under 18. The label restricts the product to adults.
• Anyone pregnant or breastfeeding, again on the label's own instruction.
• Anyone with a known allergy to any ingredient on the panel or in the other-ingredients line.
• Anyone with liver disease or a history of drug-induced liver injury, because of the ashwagandha.
• Anyone already taking a separate alpha lipoic acid supplement, unless the combined daily total has been checked.
• Anyone whose doctor has advised against supplements during a course of treatment.

The wider question of fit rather than safety is handled on who it is for, which sets out the conditions and medicines that change the answer without ruling the product out.

Some of what a reader might attribute to a capsule is a signal from the back and the leg, and confusing the two is the most dangerous thing that could happen on this page.

Two further patterns deserve an appointment rather than an emergency department: leg weakness that is worsening week by week, and back or leg pain accompanied by fever, unexplained weight loss or a history of cancer.

And one general point that outranks everything above. Sciatica is a mechanical problem, usually a disc or a narrowed spinal canal pressing on a nerve root. No capsule reaches that, this product makes no claim to, and pain that is new, severe or getting worse is a reason to be assessed rather than a reason to change supplement.